Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP
Provided By GlobeNewswire
Last update: May 12, 2025
May 12, 2025
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP
New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted in 2019
Read more at globenewswire.comNASDAQ:BDRX (8/29/2025, 8:07:57 PM)
5.54
+0.07 (+1.28%)
Find more stocks in the Stock Screener
